DK2278958T3 - Sammensætninger til oral frigivelse af kortikosteroider - Google Patents

Sammensætninger til oral frigivelse af kortikosteroider

Info

Publication number
DK2278958T3
DK2278958T3 DK09746033.1T DK09746033T DK2278958T3 DK 2278958 T3 DK2278958 T3 DK 2278958T3 DK 09746033 T DK09746033 T DK 09746033T DK 2278958 T3 DK2278958 T3 DK 2278958T3
Authority
DK
Denmark
Prior art keywords
corticosteroids
compositions
oral release
oral
release
Prior art date
Application number
DK09746033.1T
Other languages
English (en)
Inventor
Peter Watts
Ann Margaret Dyer
Original Assignee
Archimedes Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39571149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2278958(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Archimedes Dev Ltd filed Critical Archimedes Dev Ltd
Application granted granted Critical
Publication of DK2278958T3 publication Critical patent/DK2278958T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK09746033.1T 2008-05-12 2009-05-07 Sammensætninger til oral frigivelse af kortikosteroider DK2278958T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0808537.5A GB0808537D0 (en) 2008-05-12 2008-05-12 Compositions
PCT/GB2009/001150 WO2009138716A1 (en) 2008-05-12 2009-05-07 Compositions for the oral delivery of corticosteroids

Publications (1)

Publication Number Publication Date
DK2278958T3 true DK2278958T3 (da) 2014-01-20

Family

ID=39571149

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09746033.1T DK2278958T3 (da) 2008-05-12 2009-05-07 Sammensætninger til oral frigivelse af kortikosteroider

Country Status (10)

Country Link
US (1) US8491932B2 (da)
EP (1) EP2278958B1 (da)
JP (1) JP5608641B2 (da)
CN (1) CN102088962B (da)
DK (1) DK2278958T3 (da)
ES (1) ES2452265T3 (da)
GB (1) GB0808537D0 (da)
HK (1) HK1158510A1 (da)
PL (1) PL2278958T3 (da)
WO (1) WO2009138716A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS56839B1 (sr) 2012-04-30 2018-04-30 Tillotts Pharma Ag Formulacija leka sa odloženim otpuštanjem
US10799515B2 (en) 2013-10-29 2020-10-13 Tillotts Pharma Ag Delayed release drug formulation
CN104257669A (zh) * 2014-09-25 2015-01-07 合肥平光制药有限公司 一种用于向肠道递送水杨酸类药物的口服给药组合物
RU2018111690A (ru) 2015-09-11 2019-10-11 Сан Фармасьютикл Индастриз Лтд. Пероральная лекарственная форма будесонида
EP3257501A1 (en) * 2016-06-14 2017-12-20 Tillotts Pharma AG Multiple unit dosage form comprising a core with individual core units covered by a mucoadhesive material, and an enteric core coating
US11523772B2 (en) 2016-12-14 2022-12-13 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with an immunosuppressant
WO2018111326A1 (en) * 2016-12-14 2018-06-21 Progenity Inc. Methods and ingestible devices for the regio-specific release of immunosuppressants at the site of gastrointestinal tract disease
CA3067945A1 (en) * 2017-06-23 2018-12-27 Sun Pharma Advanced Research Company Limited Abuse deterrent oral solid dosage form
EP3613414A1 (de) 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon
CN110200947A (zh) * 2019-06-27 2019-09-06 深圳市泛谷药业股份有限公司 一种安非他酮肠溶缓释微丸胶囊及其制备方法
CN112999229B (zh) * 2019-12-19 2023-01-24 江苏恒瑞医药股份有限公司 一种包含布地奈德的口服药物组合物
CN117157079A (zh) * 2021-04-20 2023-12-01 江苏恒瑞医药股份有限公司 一种口服肠溶皮质类固醇的药物组合物
EP4327806A4 (en) 2021-04-20 2024-10-23 Jiangsu Hengrui Pharmaceuticals Co Ltd CAPSULE FOR SPECIFIC MEDICATION DELIVERY AND MANUFACTURING PROCESS THEREFOR
US11896719B2 (en) * 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions
WO2024013154A1 (en) 2022-07-15 2024-01-18 Synthon B.V. Budesonide two layers capsule formulation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123403A (en) 1977-06-27 1978-10-31 The Dow Chemical Company Continuous process for preparing aqueous polymer microsuspensions
US4502888A (en) 1982-12-13 1985-03-05 The Dow Chemical Company Aqueous dispersions of plasticized polymer particles
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
US5142906A (en) * 1990-07-09 1992-09-01 Westinghouse Electric Corp. Apparatus for measuring valve stem loads in a motor operated valve assembly
DE69425453T2 (de) * 1993-04-23 2001-04-12 Novartis Ag, Basel Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
DE4332394A1 (de) 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
GB9412394D0 (en) 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
SG80553A1 (en) 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
JP3185206B2 (ja) * 1995-07-20 2001-07-09 田辺製薬株式会社 消化管下部放出型被覆カプセル製剤
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
GB9722426D0 (en) 1997-10-23 1997-12-24 Univ London Pharmacy Controlled release formulations
SE514128C2 (sv) * 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
US6239120B1 (en) 1998-03-17 2001-05-29 Pharmalink Ab Method and means for treating glomerulonephritis
ITRM20010614A1 (it) 2001-10-16 2003-04-16 Italchimici S P A Preparazione farmaceutica di una soluzione idro/propilenica di budesonide e suo procedimento di preparazione.
JP2003201256A (ja) * 2001-12-28 2003-07-18 Hisamitsu Pharmaceut Co Inc 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
DE10214002A1 (de) 2002-03-27 2003-10-09 Roehm Gmbh Pharmazeutische Formulierung für den Wirkstoff Budesonid
AR041873A1 (es) 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
US20090004281A1 (en) * 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system
NZ586332A (en) * 2007-12-17 2012-07-27 Zalicus Inc Therapeutic regimens for the treatment of immunoinflammatory disorders using dipyridamole and prednisolone

Also Published As

Publication number Publication date
US8491932B2 (en) 2013-07-23
CN102088962B (zh) 2013-07-31
EP2278958B1 (en) 2014-01-01
CN102088962A (zh) 2011-06-08
JP2011519967A (ja) 2011-07-14
HK1158510A1 (en) 2012-07-20
ES2452265T3 (es) 2014-03-31
EP2278958A1 (en) 2011-02-02
JP5608641B2 (ja) 2014-10-15
US20110104269A1 (en) 2011-05-05
PL2278958T3 (pl) 2014-05-30
GB0808537D0 (en) 2008-06-18
WO2009138716A1 (en) 2009-11-19

Similar Documents

Publication Publication Date Title
DK2278958T3 (da) Sammensætninger til oral frigivelse af kortikosteroider
DK2046264T3 (da) Fremgangsmåder til fremstillingen af sammensætninger med film
DK3192500T3 (da) Sammensætninger til kontinuerlig indgivelse af dopa-decarboxylasehæmmere
DK3222716T3 (da) Sammensætninger til saccharificering af cellulosemateriale
DK2274008T3 (da) Sammensætninger og fremgangsmåder til hæmning af PDGFRBETA og VEGF-A
DK2310437T3 (da) Fremgangsmåde til kontinuerlig fremstilling af polyestere
DK3284820T3 (da) Fremgangsmåde til behandling af pyropheophytin-holdige sammensætninger
DK2345410T3 (da) Farmaceutisk sammensætning til modificeret frigivelse
DK2262793T3 (da) Krystallinske former af nilotinib-hci
DK2214646T3 (da) Dendrimers for sustained release of compounds
DK2634232T3 (da) Sammensætninger
DK2054073T3 (da) Farmaceutiske præparater til fremføring med langvarig frigivelse af peptider
DK2011486T3 (da) Farmaceutiske sammensætninger af rifaximin
DK2214679T3 (da) Kortikosteroidsammensætninger
BRPI1007025A2 (pt) composições esteroidais
EP2280916A4 (en) HYDROCHLORFLUOROLEFINZUSAMMENSETZUNGEN
BRPI0920276A2 (pt) várias composições para exclusão de exon dmd
DK2403512T3 (da) Sammensætninger af polymer myrcen
ES2628203T8 (es) Composiciones antitranspirantes
DK1884507T3 (da) Fremgangsmåde til fremstilling af glycerol
DK2114853T3 (da) Fremgangsmåde til fremstilling af glycerolestere
DK2358714T3 (da) Alkylcyclohexylethere af dihydrotetraazabenzoazulener
DK2408446T3 (da) Anvendelse af farmaceutiske sammensætninger, der indeholder mesembrenon
DK3214083T3 (da) Fremgangsmåde til fremstilling af quinolonforbindelser
EP2280032A4 (en) PHOTOPOLYMERIZABLE COMPOSITIONS